Skip to content
PICO Portalanswers from OpenAlex

SARS‐CoV‐2 reactive infectious mucocutaneous eruptions in adults treated with cyclosporine as first line treatment

PaperCitations, authors & open-access status

SARS‐CoV‐2 reactive infectious mucocutaneous eruptions in adults treated with cyclosporine as first line treatment is a paper indexed in PICO Portal from OpenAlex.

How many citations does SARS‐CoV‐2 reactive infectious mucocutaneous eruptions in adults treated with cyclosporine as first line treatment have?

PICO Portalcitation count

SARS‐CoV‐2 reactive infectious mucocutaneous eruptions in adults treated with cyclosporine as first line treatment has 5 citations in the OpenAlex counts PICO Portal stores.

When was SARS‐CoV‐2 reactive infectious mucocutaneous eruptions in adults treated with cyclosporine as first line treatment published?

PICO Portalyear

SARS‐CoV‐2 reactive infectious mucocutaneous eruptions in adults treated with cyclosporine as first line treatment has 2024 year in the PICO Portal index.

What is the open-access status of SARS‐CoV‐2 reactive infectious mucocutaneous eruptions in adults treated with cyclosporine as first line treatment?

PICO Portaloa status

SARS‐CoV‐2 reactive infectious mucocutaneous eruptions in adults treated with cyclosporine as first line treatment has hybrid oa status in the PICO Portal index.

What is the DOI of SARS‐CoV‐2 reactive infectious mucocutaneous eruptions in adults treated with cyclosporine as first line treatment?

PICO Portaldoi

The DOI for SARS‐CoV‐2 reactive infectious mucocutaneous eruptions in adults treated with cyclosporine as first line treatment is on the source record.

What is the PMID of SARS‐CoV‐2 reactive infectious mucocutaneous eruptions in adults treated with cyclosporine as first line treatment?

PICO Portalpmid

The PMID for SARS‐CoV‐2 reactive infectious mucocutaneous eruptions in adults treated with cyclosporine as first line treatment is on the source record.

What is the OpenAlex record for SARS‐CoV‐2 reactive infectious mucocutaneous eruptions in adults treated with cyclosporine as first line treatment?

PICO Portalopenalex

The OpenAlex for SARS‐CoV‐2 reactive infectious mucocutaneous eruptions in adults treated with cyclosporine as first line treatment is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial